| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/25/2002 | WO2001055361A3 Recombinant AAV packaging systems |
| 04/25/2002 | US20020048806 Poultry virus isolates and method |
| 04/25/2002 | CA2426172A1 Nucleic acid amplification controls |
| 04/24/2002 | EP1199368A2 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 04/24/2002 | EP1198581A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 04/24/2002 | EP1198580A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/24/2002 | EP1198475A1 Highly purified cytokine activating factor and methods of use |
| 04/24/2002 | EP1198468A1 Stabilized viral envelope proteins and uses thereof |
| 04/23/2002 | US6376237 Stock of recombinant adeno-associated virus; containing a heterologous gene of interest but lacking adeno-associated virus genes required for replication or packaging of said adeno-associated virus vector |
| 04/23/2002 | US6376172 Composition comprising mink lung cells and another cell type, suitable for detection of virus selected from influenza virus and parainfluenza virus |
| 04/23/2002 | US6375952 Isolated herpes simplex virus polypeptide |
| 04/23/2002 | US6375929 Gene therapy for inhibition of angiogenesis |
| 04/18/2002 | WO2002031170A1 Method for circularizing adenoviral nucleic acid via homologous recombination |
| 04/18/2002 | WO2002031139A1 Compulsive transporter expression vector for organ infection |
| 04/18/2002 | WO2002031137A2 Cytomegalovirus intron a fragments |
| 04/18/2002 | WO2002007742A9 Bacteriophage having multiple host range |
| 04/18/2002 | WO2002004596A3 Diagnosing and treating cancer cells using mutant viruses |
| 04/18/2002 | WO2002004007A3 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof |
| 04/18/2002 | WO2001088141A3 Synthetic gagpol genes and their uses |
| 04/18/2002 | WO2001057073A3 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 04/18/2002 | WO2000073482A9 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 04/18/2002 | US20020045264 Expression vectors for use in gene therapy |
| 04/18/2002 | US20020045239 Transducing phages |
| 04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |
| 04/18/2002 | CA2424323A1 Method for circularizing adenoviral nucleic acid via homologous recombination |
| 04/17/2002 | EP1196616A2 Replication-competent anti-cancer vectors |
| 04/17/2002 | EP1196597A2 Linoleate isomerase |
| 04/17/2002 | EP1196596A1 Mosaic infectious bursal disease virus vaccines |
| 04/17/2002 | EP1196573A1 A human lactoferrin produced by using an insect cell and method using the same |
| 04/17/2002 | EP1196552A2 Methods and compositions for engineering of attenuated vaccines |
| 04/17/2002 | EP1196435A1 Recombinant adenovirus |
| 04/17/2002 | EP1196197A2 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| 04/17/2002 | EP0918793B1 Inactivating process for lipid envelopped virus, and new antiviral lipopeptides |
| 04/17/2002 | EP0826047B1 Recombinant baculovirus insecticides |
| 04/17/2002 | CN1344797A No.6 gene segment of rice dwarfing virus |
| 04/16/2002 | US6372944 Liquid withdrawing tray for purification column, purification column, and method for purification |
| 04/16/2002 | US6372455 As vaccines and anticancer agents |
| 04/16/2002 | US6372221 Immunogenic constructs comprising flaviviruses or flavivirus derivatives |
| 04/11/2002 | WO2002029075A2 Multiple inducible gene regulation system |
| 04/11/2002 | WO2002029074A2 Genetic immunisation against cervical carcinoma |
| 04/11/2002 | WO2002029065A2 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | WO2002028892A1 Von willebrand factor-binding proteins from staphylococci |
| 04/11/2002 | WO2002028426A1 Split enveloped virus preparation |
| 04/11/2002 | WO2002028351A2 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 04/11/2002 | WO2001092464A3 Therapeutic vaccine preparation and treatment for hiv viral infection |
| 04/11/2002 | WO2001089559A3 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
| 04/11/2002 | WO2001068833A3 Recombinant hhv8 dna |
| 04/11/2002 | WO2000058444A9 Adaptation of virus to vertebrate cells |
| 04/11/2002 | WO2000057907A9 Multivalent dengue virus vaccine |
| 04/11/2002 | WO2000042068A9 Hiv related peptides |
| 04/11/2002 | US20020042136 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 04/11/2002 | US20020042135 Kit for in transform and expression of heterologous gene in bacterial |
| 04/11/2002 | US20020042045 METHODS FOR THE DETECTION OF HTLV-II ANTIBODIES EMPLOYIING NOVEL HTLV-II nra ENVELOPE PEPTIDES |
| 04/11/2002 | US20020041869 Methods for treating cells |
| 04/11/2002 | CA2424738A1 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | CA2423610A1 Split enveloped virus preparation |
| 04/10/2002 | EP1195439A2 Retroviral vector with heterologous sequences between the retroviral primer binding site and the retroviral splice donor site |
| 04/10/2002 | EP1195438A1 Genetic immunisation against cervical carcinoma |
| 04/10/2002 | EP1194581A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 04/10/2002 | EP1194580A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 04/10/2002 | EP1194529A1 Composition for the preservation of infectious recombinant adenoviruses |
| 04/10/2002 | EP1194450A1 Inactivated vaccine against feline calicivirus disease |
| 04/10/2002 | EP0694070B1 Recombinant alphavirus vectors |
| 04/10/2002 | EP0607206B1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344170A Methods for inactivating pathogens using broad-spectrum pulsed light |
| 04/09/2002 | US6369394 Method and apparatus for irradiating a biological fluid |
| 04/09/2002 | US6368863 Reagents and methods for modulating gene expression through RNA mimicry |
| 04/09/2002 | US6368852 A peptide capable of inducing cytotoxic t lymphocytes, immune response; anticarcinogenic agents |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368832 A polypeptide of a major capsid protein; diagnosis and therapy for skin cancer; vaccines |
| 04/09/2002 | US6368602 Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine |
| 04/09/2002 | US6368601 Isolated dna |
| 04/06/2002 | CA2358179A1 Anti-inflammatory vectors |
| 04/04/2002 | WO2002026943A2 Production of virus-like hcv particles in the cells of insects |
| 04/04/2002 | WO2002026209A2 Microparticles for delivery of the heterologous nucleic acids |
| 04/04/2002 | WO2002026192A2 Viruses targeted to hypoxic cells and tissues |
| 04/04/2002 | WO2002026040A1 Irreversible coating particles and compositions containing these particles |
| 04/04/2002 | WO2001071017A3 Modified nodavirus rna for gene delivery |
| 04/04/2002 | WO2001068695A3 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 04/04/2002 | WO2001066566A3 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids |
| 04/04/2002 | WO2000057909A9 Attenuated dengue-2 virus vaccine |
| 04/04/2002 | US20020039729 Methods & compositions for identifying a protease |
| 04/03/2002 | EP1192948A2 Use of HSV mutant in the treatment of cancer |
| 04/03/2002 | EP1192266A2 Complement-resistant non-mammalian dna viruses and uses thereof |
| 04/03/2002 | EP1192265A1 Anti-viral vectors |
| 04/03/2002 | EP1192245A2 Methods for the propagation of lytic organisms |
| 04/03/2002 | EP0856051B1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 04/03/2002 | EP0833661B1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 04/03/2002 | CN1343257A Recombined procine adenovirus based viral vaccines and vectors |
| 04/03/2002 | CN1342753A Hepatitis C virus and its external cell culture method |
| 04/02/2002 | US6365403 High-efficiency AAV helper functions |
| 04/02/2002 | US6365394 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/02/2002 | US6365393 Recombinant virus with an insertion in the hind iii fragment i region; immunomodulators |
| 04/02/2002 | US6365392 Amino acid sequences; anthelmintics; nematocides; vaccines; for veterinary medicine |
| 04/02/2002 | CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody |
| 03/28/2002 | WO2002024933A2 Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells |
| 03/28/2002 | WO2002024876A2 Live influenza vaccine and method of manufacture |
| 03/28/2002 | WO2002024734A2 Influenza a virus haemagglutinin subtype h16 proteins and their encoding nuclei c acid |
| 03/28/2002 | WO2002024147A2 Avian pneumovirus vaccine |